50/FIFTY

Today's stories, rewritten neutrally

Mar 5

Calidi Biotherapeutics plans public offering of stock, pre-funded warrants; shares down

Synthesized from 1 source

Sources (1)

Bias Scale:
LeftCenterRight

Comments

No comments yet. Be the first!